DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 214 filers reported holding DENALI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $400,036 | +10.4% | 19,391 | +48.8% | 0.01% | -20.0% |
Q4 2022 | $362,336 | -19.1% | 13,029 | -10.8% | 0.01% | -23.1% |
Q3 2022 | $448,000 | -0.4% | 14,607 | -4.4% | 0.01% | -7.1% |
Q2 2022 | $450,000 | +67.9% | 15,285 | +187.5% | 0.01% | +27.3% |
Q3 2021 | $268,000 | -64.2% | 5,317 | -44.3% | 0.01% | -65.6% |
Q2 2021 | $748,000 | -48.1% | 9,539 | -62.2% | 0.03% | -50.0% |
Q1 2021 | $1,441,000 | +126.6% | 25,241 | +232.3% | 0.06% | +204.8% |
Q4 2020 | $636,000 | – | 7,595 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 19,462,500 | $404,042,000 | 54.41% |
Bratton Capital Management, L.P. | 953,035 | $19,785,000 | 29.05% |
Flagship Pioneering Inc. | 8,005,747 | $166,199,000 | 7.19% |
Casdin Capital, LLC | 400,000 | $8,304,000,000 | 0.78% |
Temasek Holdings (Private) Ltd | 4,410,457 | $91,561,000 | 0.65% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 22,595 | $469,000 | 0.37% |
MARK ASSET MANAGEMENT LP | 70,532 | $1,464,000 | 0.34% |
Artal Group S.A. | 400,000 | $8,304,000 | 0.34% |
PIER 88 INVESTMENT PARTNERS LLC | 27,650 | $574,000 | 0.24% |
WASATCH ADVISORS LP | 996,147 | $20,680,000 | 0.20% |